Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Contacto piel con piel durante el traslado de la sala de partos a la unidad de cuidados intensivos neonatales: impacto en los recién nacidos muy prematuros y sus padres (TRANSPAPNEO)

4 de noviembre de 2026 actualizado por: University Hospital, Tours

Evaluación del contacto piel con piel durante el traslado de recién nacidos muy prematuros desde la sala de partos a la unidad de cuidados intensivos neonatales: un ensayo aleatorizado, controlado, de no inferioridad, abierto, en comparación con el traslado en incubadora

Developmental care are recognized as a standard of care for preterm infants in neonatal intensive care units. Regular skin-to skin contacts during the neonatal stay show short and long-term beneficial effects on preterm infants and their parents. Skin-to-skin contact provides hemodynamic and thermal stability in preterm infants. Regarding parents, skin-to-skin contact sustains the parental bonding, and reduces stress and anxiety related to hospitalization. As a result, early skin-to-skin contact has been associated with an improvement of neurological outcome in very preterm infants.

Thermal stability is crucial during the first hour of life in preterm infants. A temperature at admission in the neonatal intensive care unit below 36.5°C or above 37.2°C has been associated with an increase in neonatal morbidity and mortality.

Early skin-to-skin contact between a newborn and his/her mother in the delivery room significantly decreases the occurrence of hypothermia below 35.5°C.

The practice of skin-to-skin transfer from the delivery room is emerging in France. Pilot studies have been carried out by French neonatal teams that showed the feasibility of this practice in late-preterm, near-term and term infants. Although skin-to-skin contact routinely involves very preterm infants in neonatal intensive care units worldwide, the feasibility and safety of skin-to-skin contact during the transfer from delivery room to the neonatal unit is poorly documented in very preterm infants. Previous data of our team showed that transfer of preterm infants with non-invasive ventilation using skin-to-skin contact was feasible and safe but concerns emerged about the thermal conservation during the procedure.

The main hypothesis of this study is that skin-to skin contact during the transfer from the delivery room to the neonatal intensive care unit could prevent heat losses in preterm infants as well as the transfer in incubator. Another hypothesis is that very early skin-to-skin contact could positively influence the neonatal course and the parental experience in the neonatal care unit.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

118

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Angers, Francia, 49000
        • CHU Angers
      • Orléans, Francia, 45000
        • Neonatal medicine and intensive care unit, University Hospital, Orléans
      • Toulouse, Francia, 31300
        • Neonatology service, University Hospital, Toulouse
      • Tours, Francia, 37000
        • Neonatal and paediatric service, University Hospital, Tours

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

5 meses a 7 meses (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Gestational age < 34 weeks
  • Singleton pregnancy
  • Inborn birth, i.e., in the maternity ward of investigating centres
  • Need of hospitalization in the neonatal intensive care unit
  • Oral and written information of parents and written parental consent to participate in the study (by the father if the mother is unable to participate)

Exclusion Criteria:

  • Single parent or homosexual couple
  • Absence of the father in the delivery room
  • Parents not speaking French
  • Skin temperature of the newborn < 36°C at the time of randomization
  • Conditions not allowing the early skin-to-skin contact: omphalocele, gastroschisis, desquamating dermatological conditions (Harlequin syndrome, Collodion)
  • Clinical condition requiring a specific transfer mode according to the pediatrician in the delivery room
  • Parents under legal protection
  • Minor parents

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Skin-to-skin contact during the transfer between the delivery room and the neonatal care unit

Preterm infants will be transferred using a direct skin-to-skin contact with their father from the delivery room to the intensive neonatal care.

For the Skin-to-skin Contact (SSC) transfer, the bare-chested father will seat in a wheelchair. Newborns who will wear only a diaper and a cotton cap or noninvasive ventilation headgear will be placed in the kangaroo position against the father's chest to ensure direct contact with the father's skin. Preterm infants with gestational age less than 33 weeks will be wrapped with their father using plastic bags plus warmed cotton towels. More gestationally mature infants will be wrapped with only warmed cotton wraps. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

Comparador activo: Transfer in incubator between the delivery room and the neonatal care unit

Preterm infants will be transferred in an incubator set to 36°C from the delivery room to the intensive neonatal care.

In the incubator group, infants will be transferred after resuscitation in an incubator with air temperature set to 36°C. The newborn will be laid on his/her back in a polyethylene bag with a cap. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in the infant skin temperature due to the transfer procedure
Periodo de tiempo: During the transfer procedure

Fluctuation in the infant skin temperature between the randomization in the delivery room and the admission in the neonatal intensive care unit (NICU)

During the transfer procedure

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in the infant's heart rate during the transfer procedure
Periodo de tiempo: During the transfer procedure

Heart rate values during the transfer procedure

During the transfer procedure
Occurrence of bradycardia episodes in infant during the transfer procedure
Periodo de tiempo: During the transfer procedure

Rapid decrease in heart rate less than 100 beats/min that lasts at least 10 secondes during the transfer procedure

During the transfer procedure
Change in the infant's oxygen saturation during the transfer procedure
Periodo de tiempo: During the transfer procedure

Oxygen saturation values during the transfer procedure

During the transfer procedure
Occurrence of desaturation episodes in infant during the transfer procedure
Periodo de tiempo: During the transfer procedure

Decrease in oxygen saturation less than 85% that last at least 10 secondes

During the transfer procedure
Change in the infant's fraction of inspired oxygen during the transfer procedure
Periodo de tiempo: During the transfer procedure

Fraction of inspired oxygen values during the transfer procedure

During the transfer procedure
Duration of the transfer procedure
Periodo de tiempo: During the transfer procedure

Time (in min) during the transfer procedure

During the transfer procedure
First Hydrogen Potential (pH) of the newborn
Periodo de tiempo: First blood gas in the NICU

First assessment of pH in the neonatal intensive care unit (NICU)

First blood gas in the NICU
Carbon dioxide partial pressure (pCO2) of the newborn
Periodo de tiempo: First blood gas in the NICU

First assessment of carbon dioxide partial pressure (pCO2) in the neonatal intensive care unit (NICU)

First blood gas in the NICU
Blood glucose of the newborn
Periodo de tiempo: First blood glucose measurement in the NICU

First assessment of blood glucose in the neonatal intensive care unit (NICU)

First blood glucose measurement in the NICU
Occurence of hypothermia
Periodo de tiempo: From admission in the neonatal intensive care unit to 30 min later

Decrease of skin temperature less than 36°C

From admission in the neonatal intensive care unit to 30 min later
Time to the first skin-to-skin contact in the neonatal care unit
Periodo de tiempo: Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit

Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit

Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit
Practice of skin-to-skin contact in the neonatal intensive care unit (NICU) during the first week of life
Periodo de tiempo: During the first 7 days of the stay in the neonatal care unit

Frequency of skin-to-skin contact (Postnatal day and hour), length of each skin-to-skin contact, which parent involves in each skin-to-skin contact episode.

During the first 7 days of the stay in the neonatal care unit
Quality of parental bond
Periodo de tiempo: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Assessment through a maternal questionnaire: Mother-to-Infant Bonding Scale (MIBS) questionnaire (Mother-to-infant bonding scale - Taylor, 2005). Only the infant's mother will be invited to fill out this questionnaire.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Parental stress
Periodo de tiempo: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Parental stress assessed by Perceived Stress Scale (PSS) - Neonatal Intensive Care Unit (NICU) questionnaire (Perceived Stress Scale Neonatal Intensive Care Unit - Miles, 1993). The infant's mother and father will be invited to fill out this questionnaire.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Parental post-traumatic stress disorder
Periodo de tiempo: At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Parental post-traumatic stress disorder assessed by Perinatal Post traumatic stress disorder Questionnaire (PPQ) - DEMIER, 1996). The infant's mother and father will be invited to fill out this questionnaire.

At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Infant growth: Weight
Periodo de tiempo: At birth and weight at the postmenstrual age of 36 weeks

Weight at birth and at the postmenstrual age of 36 weeks

At birth and weight at the postmenstrual age of 36 weeks
Infant growth: Height
Periodo de tiempo: At birth and at the postmenstrual age of 36 weeks

Height at birth and at the postmenstrual age of 36 weeks

At birth and at the postmenstrual age of 36 weeks
Infant growth: Head circumference
Periodo de tiempo: At birth and at the postmenstrual age of 36 weeks

Head circumference at birth and at the postmenstrual age of 36 weeks

At birth and at the postmenstrual age of 36 weeks
Neonatal morbidity and mortality at the postmenstrual age of 36 weeks
Periodo de tiempo: At the postmenstrual age of 36 weeks

Death

  • Intraventricular hemorrhage (maximal grade),
  • Periventricular leukomalacia, Necrotizing enterocolitis (> stade 2 of the Bell classification),
  • Neonatal surgery,
  • Early onset sepsis (onset before postnatal day 2 and > 3 days of intravenous antibiotherapy),
  • Late onset sepsis (Blood culture positive, number of events),
  • Number of red blood cell transfusions,
  • Duration of mechanical ventilation (days).
  • Severe bronchopulmonary dysplasia,
  • Retinopathy of prematurity that requires laser photocoagulation or intravitreal injection of proangiogenic factor,
  • Length of stay in neonatal intensive care unit (days).
At the postmenstrual age of 36 weeks
Modalities of breastfeeding
Periodo de tiempo: During the NICU stay: infant postnatal day

First breastfeeding attempt in the neonatal intensive care unit (NICU)

During the NICU stay: infant postnatal day
Modalities of breastfeeding
Periodo de tiempo: At the postmenstrual age of 36 weeks

Presence of complete or partial breastfeeding at the postmenstrual age of 36 weeks

At the postmenstrual age of 36 weeks
Mode of infant feeding at the postmenstrual age of 36 weeks
Periodo de tiempo: At the postmenstrual age of 36 weeks

Modes of infant feeding that include breastfeeding, breastmilk given through a bottle, artificial formula

At the postmenstrual age of 36 weeks

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Self-questionnaires to study parents' experience of their infant hospitalization
Periodo de tiempo: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Ancillary study: Self-questionnaires to study parents' experience of their infant hospitalization to assess stress at different times.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Director de estudio: Nolwenn CLENET, University Hospital, Tours

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

3 de mayo de 2023

Finalización primaria (Actual)

10 de marzo de 2026

Finalización del estudio (Actual)

15 de abril de 2026

Fechas de registro del estudio

Enviado por primera vez

23 de marzo de 2023

Primero enviado que cumplió con los criterios de control de calidad

6 de abril de 2023

Publicado por primera vez (Actual)

19 de abril de 2023

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

4 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • DR210297

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir